Money talks, and the drug industry's dollar talks loud and clear through the pages of leading medical journals. That's the conclusion of Peter Gøtzsche and his team at the Nordic Cochrane Centre in Copenhagen, Denmark, who compared reviews of drug studies funded by pharmaceutical companies with similar reviews done without industry support.
Via: New Scientist


Comments